This session will focus on various CF pharmacotherapy issues facing practitioners today. The topics that will discussed are the standardization and improvement in the rate of Pseudomonas aeruginosa eradication, collaborative efforts of an integrated healthcare system CF team on medication delivery, analysis of tobramycin serum concentration monitoring strategies (central vs peripheral line collections), the impact of the addition of a dedicated-CF pharmacy technician to an ambulatory CF clinic team, and the evaluation of the impact of pharmacist-driven interventions on medication adherence and outcomes on CFTR modulator therapy.
Describe the process involved to improve the rate of eradication of Pseudomonas aeruginosa.
Explain the impact of dedicated ambulatory CF pharmacy technicians and pharmacists on CF medication delivery, adherence, etc.
Discuss the difference in tobramycin serum concentration monitoring strategies between peripheral vein and central-line collections.